OnKure Therapeutics, Inc.
OKUR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001637715
In the last 90 days, OnKure Therapeutics, Inc. insiders filed 0 open-market purchases and 2 sales; 75 institutions reported holding it in 13F filings for Q2 2026, worth $159.0M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in OnKure Therapeutics, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 47
- −4 vs. Q4 2024
- Shares held
- 11.9M
- +105.9K (+0.9%) vs. Q4 2024
- Total value
- $50.1M
- −$49.1M (−49.5%) vs. Q4 2024
- New holders
- 4
- 15 more added
- Sold out
- 8
- 13 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting OKUR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 75 | $159.0M |
| Q1 2026 | 51 | $113.9M |
| Q4 2025 | 44 | $32.0M |
| Q3 2025 | 42 | $28.1M |
| Q2 2025 | 49 | $25.8M |
| Q1 2025 | 47 | $50.1M |
| Q4 2024 | 51 | $99.2M |
| Q3 2024 | 51 | $49.0M |
| Q2 2024 | 66 | $41.3M |
| Q1 2024 | 62 | $45.4M |
| Q4 2023 | 68 | $40.4M |
| Q3 2023 | 58 | $208.3M |
| Q2 2023 | 52 | $168.9M |
| Q1 2023 | 35 | $102.0M |
| Q4 2022 | 32 | $38.4M |
| Q3 2022 | 33 | $55.1M |
| Q2 2022 | 33 | $43.3M |
| Q1 2022 | 41 | $50.8M |
| Q4 2021 | 39 | $148.9M |
| Q3 2021 | 38 | $136.7M |
| Q2 2021 | 38 | $170.6M |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding OnKure Therapeutics, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 32 | $0 | 0.00% | −11−25.6% | Reduced |
| MAI Capital Management | 6 | $26 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 56 | $241 | 0.00% | −233−80.6% | Reduced |
| Citigroup Inc | 190 | $818 | 0.00% | +88+86.3% | Added |
| Bank of America Corp | 221 | $950 | 0.00% | −249,421−99.9% | Reduced |
| JPMorgan Chase & Co | 231 | $993 | 0.00% | −106−31.5% | Reduced |
| UBS Group AG | 280 | $1.20K | 0.00% | −1,933−87.3% | Reduced |
| BNP Paribas Arbitrage, SA | 297 | $1.28K | 0.00% | +61+25.8% | Added |
| GF Fund Management Co. Ltd. | 313 | $1.35K | 0.00% | +47+17.7% | Added |
| Mirae Asset Global Investments Co., Ltd. | 423 | $1.89K | 0.00% | +1+0.2% | Added |
| Morgan Stanley | 1,878 | $8.08K | 0.00% | +946+101.5% | Added |
| Tower Research Capital LLC (TRC) | 2,224 | $9.56K | 0.00% | +23+1.0% | Added |
| China Universal Asset Management Co., Ltd. | 2,538 | $10.9K | 0.00% | −145−5.4% | Reduced |
| Wells Fargo & Company | 3,620 | $15.6K | 0.00% | +2,000+123.5% | Added |
| Barclays PLC | 6,765 | $29.1K | 0.00% | −1,976−22.6% | Reduced |
| ADAR1 Capital Management, LLC | 10,000 | $43.0K | 0.01% | +10,000 | New |
| Qube Research & Technologies Ltd | 18,663 | $80.3K | 0.00% | +18,663 | New |
| Northern Trust Corp | 19,177 | $82.5K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 25,000 | $107.5K | 0.00% | +25,000 | New |
| Two Sigma Investments, LP | 27,148 | $116.7K | 0.00% | +27,148 | New |
| Two Sigma Advisers, LP | 27,628 | $118.8K | 0.00% | +13,400+94.2% | Added |
| Renaissance Technologies LLC | 41,863 | $180.0K | 0.00% | −5,587−11.8% | Reduced |
| Aldebaran Capital, LLC | 45,048 | $193.7K | 0.18% | −524−1.1% | Reduced |
| Nantahala Capital Management, LLC | 54,208 | $233.1K | 0.02% | −569−1.0% | Reduced |
| Boothbay Fund Management, LLC | 78,021 | $335.5K | 0.01% | 00.0% | Unchanged |
| Sphera Funds Management Ltd. | 80,454 | $346.0K | 0.09% | −6,900−7.9% | Reduced |
| Geode Capital Management, LLC | 86,311 | $371.2K | 0.00% | +9,712+12.7% | Added |
| Aisling Capital Management LP | 88,607 | $381.0K | 0.13% | 00.0% | Unchanged |
| BlackRock, Inc. | 88,981 | $382.6K | 0.00% | −5,036−5.4% | Reduced |
| Cantor Fitzgerald, L. P. | 130,700 | $562.0K | 0.02% | +95,000+266.1% | Added |
| Shay Capital LLC | 151,038 | $649.5K | 0.19% | +136,022+905.8% | Added |
| Prosight Management, LP | 186,570 | $802.3K | 0.26% | +122,816+192.6% | Added |
| Ikarian Capital, LLC | 253,754 | $1.09M | 0.36% | 00.0% | Unchanged |
| Carlyle Group Inc. | 269,895 | $1.16M | 0.03% | 00.0% | Unchanged |
| Affinity Asset Advisors, LLC | 394,159 | $1.69M | 0.27% | +250,000+173.4% | Added |
| Tang Capital Management LLC | 400,000 | $1.72M | 0.10% | +105,374+35.8% | Added |
| Highbridge Capital Management LLC | 438,797 | $1.89M | 0.08% | +39,054+9.8% | Added |
| NEA Management Company, LLC | 478,548 | $2.06M | 0.16% | 00.0% | Unchanged |
| StepStone Group LP | 491,938 | $2.12M | 2.17% | 00.0% | Unchanged |
| Deep Track Capital, LP | 523,989 | $2.25M | 0.07% | 00.0% | Unchanged |
| Vestal Point Capital, LP | 635,000 | $2.73M | 0.19% | 00.0% | Unchanged |
| Vanguard Group Inc | 706,733 | $3.04M | 0.00% | 00.0% | Unchanged |
| Samsara BioCapital, LLC | 824,155 | $3.54M | 0.63% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 1,004,439 | $4.32M | 0.15% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,068,104 | $4.44M | 0.00% | −6,210−0.6% | Reduced |
| Acorn Capital Advisors, LLC | 1,439,674 | $5.12M | 3.42% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 1,837,739 | $7.90M | 0.60% | 00.0% | Unchanged |
| Altium Capital Management LP | 0 | $0 | 0.00% | −218,386−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −144,099−100.0% | Sold out |
| 683 Capital Management, LLC | 0 | $0 | 0.00% | −43,371−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −20,549−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −18,633−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −13,495−100.0% | Sold out |
| Omers Administration Corp | 0 | $0 | 0.00% | −12,100−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −152−100.0% | Sold out |